Biotechnology

Company Overview of Innovir Laboratories Inc.

Company Overview

As per the transaction announced in August 1999, Innovir Laboratories, Inc. was acquired by Sirna Therapeutics Inc. Innovir Laboratories, Inc. develops technology to be used as a research tool to facilitate determination of gene function, and to validate drug targets. The company continues to seek partners, investors or purchasers for its core oligozyme technology including the lead EGS, the FRS/GSFRS, the RILON technology and related research technologies. Innovir has no commercially viable therapeutic products, and does not anticipate having any for several years. Since its inception, substantially all of its resources have been applied to research and development, patents and licensing, a...

As per the transaction announced in August 1999, Innovir Laboratories, Inc. was acquired by Sirna Therapeutics Inc. Innovir Laboratories, Inc. develops technology to be used as a research tool to facilitate determination of gene function, and to validate drug targets. The company continues to seek partners, investors or purchasers for its core oligozyme technology including the lead EGS, the FRS/GSFRS, the RILON technology and related research technologies. Innovir has no commercially viable therapeutic products, and does not anticipate having any for several years. Since its inception, substantially all of its resources have been applied to research and development, patents and licensing, and other general and administrative matters.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.